Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Stockholders' Equity (Deficit)

v3.23.1
Consolidated Statements of Changes in Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Series B1 Preferred Stock
Common Stock
Common Stock
Series B1 Preferred Stock
Common Stock
Series D Preferred Stock
Additional Paid-in Capital
Additional Paid-in Capital
Series B1 Preferred Stock
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning Balance (in Shares) at Dec. 31, 2020     32,184,263            
Beginning Balance at Dec. 31, 2020 $ (1,847)   $ 3     $ 112,994   $ (114,567) $ (277)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issance of Legacy Shapeways common stock upon exercise of stock options (in shares)     1,212,430            
Issuance of Legacy Shapeways common stock upon exercise of stock options 552         552      
Issuance of Legacy Shapeways convertible Series preferred stock resulting from exercise of warrants (in shares)       19,177 89,217        
Issuance of Legacy Shapeways convertible Series preferred stock resulting from exercise of warrants   $ 60         $ 60    
Issuance of Legacy Shapeways common stock upon conversion of convertible notes (in shares)     1,406,741            
Issuance of Legacy Shapeways common stock upon conversion of convertible notes 5,913         5,913      
Issuance of Legacy Shapeways common stock upon exercise of warrants (in shares)     212,234            
Repurchase of Legacy Shapeways common stock (in shares)     (19,226)            
Repurchase of Legacy Shapeways common stock (152)         (152)      
Effect of Merger and recapitalization, net of redemptions and issuance costs (in shares)     5,691,648            
Effect of Merger and recapitalization, net of redemptions and issuance costs 10,036   $ 1     10,035      
Issuance of common stock pursuant to PIPE financing, net of issuance costs (in shares)     7,500,000            
Issuance of common stock pursuant to PIPE financing, net of issuance costs 64,937   $ 1     64,936      
Issuance of common stock resulting from exercise of stock options (in shares)     86,533            
Issuance of common stock resulting from exercise of stock options 43         43      
Issuance of common stock for settlement of restricted stock units (in shares)     410,000            
Issuance of common stock for settlement of restricted stock units 1,558         1,558      
Tax payments related to shares withheld for vested restricted stock units (in shares)     (165,278)            
Tax payments related to shares withheld for vested restricted stock units (594)         (594)      
Stock-based compensation expense 1,349         1,349      
Transfer of Private Warrants to Public Warrants 1,485         1,485      
Net (loss) income 1,756             1,756  
Foreign currency translation adjustment (92)               (92)
Ending Balance at Dec. 31, 2021 $ 85,004   $ 5     198,179   (112,811) (369)
Ending Balance (in shares) at Dec. 31, 2021 48,627,739   48,627,739            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock resulting from exercise of stock options (in shares) 687,624                
Stock issued for stock-based compensation (in shares)     819,166            
Issuance of common stock for stock-based compensation $ 339         339      
Cancellation of restricted stock (in shares)     (1,731)            
Stock-based compensation expense 2,155         2,155      
Transfer of Private Warrants to Public Warrants 689         689      
Net (loss) income (20,221)             (20,221)  
Foreign currency translation adjustment (175)               (175)
Ending Balance at Dec. 31, 2022 $ 67,791   $ 5     $ 201,362   $ (133,032) $ (544)
Ending Balance (in shares) at Dec. 31, 2022 49,445,174   49,445,174